Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Stopping Rituximab vs. Continuing Rituximab for Patients with ANCA-Associated Vasculitis in Stable Remission

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Denmark Ireland The Netherlands Sweden
  • Study on the Effects of Botulinum Toxin in Patients with Jaw Muscle Pain (TMD)

    Recruiting

    2 1 1 1
    Sweden
  • Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Germany Hungary Italy Poland +1
  • Study on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

    Recruiting

    3 1 1 1
    Investigated drugs:
    Poland Spain
  • Study Comparing Sirolimus and Methylprednisolone for Patients with Active Thyroid Eye Disease

    Recruiting

    3 1 1 1
    Norway
  • Long-Term Safety Study of GLM101 for Patients with PMM2-CDG

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Italy Portugal Spain
  • Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma

    Recruiting

    1 1 1 1
    Austria France Germany Italy The Netherlands Poland +1
  • Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

    Recruiting

    3 1
    Investigated drugs:
    Austria Bulgaria Croatia Czechia Germany Greece +9
  • Study of Lenvatinib, Pembrolizumab, and Chemotherapy Combination for Patients with Advanced Esophageal Cancer Previously Treated with PD-1/PD-L1 Therapy

    Recruiting

    1 1 1 1
    Germany Italy Norway
  • Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

    Recruiting

    2 1 1 1
    Spain Sweden